Melissa Officinalis Whole

Dosage for Melissa Officinalis Whole is not calculated like traditional medications (e.g., mg/kg). Instead, it is based on biological potency or weight/volume (w/v) concentrations.

• Skin Prick Testing (SPT): A single drop of the extract (typically at a concentration of 1:10 or 1:20 w/v) is applied to the skin, followed by a puncture through the drop using a sterile lancet.
• Intradermal Testing: If the SPT is negative, a dose of 0.02 mL to 0.05 mL of a highly diluted extract (e.g., 1:1000 w/v) may be injected into the intradermal layer of the skin.
• Immunotherapy: Dosing begins with an extremely low 'starting dose' (e.g., 0.05 mL of a 1:100,000 w/v dilution) and is gradually increased weekly (escalation phase) until a maintenance dose is reached, based on patient tolerance.

Melissa Officinalis Whole is generally considered safe for use in children for diagnostic purposes, provided it is administered by a pediatric allergist.

• Infants and Children: The procedure for skin prick testing is identical to adults, though the number of tests performed at one time may be limited to minimize discomfort and the risk of systemic absorption.
• Dose Adjustment: No specific dose adjustment is required for children, but the interpretation of the wheal size must account for the smaller surface area of a child's arm or back.

Renal Impairment

No dosage adjustments are necessary for patients with renal impairment, as the systemic absorption of the diagnostic extract is negligible and it is not cleared by the kidneys in a manner that would affect its safety or efficacy.

Hepatic Impairment

No dosage adjustments are required for patients with hepatic impairment. The local mechanism of action does not involve hepatic metabolism.

Elderly Patients

In elderly patients (over 65 years), skin reactivity may be diminished due to age-related changes in skin turgor and mast cell density. While no dose adjustment is needed, healthcare providers should be aware that a smaller wheal size may still indicate a significant allergy.

Melissa Officinalis Whole extract is not for self-administration. It must be administered by a healthcare professional in a clinical setting.

1. 1Preparation: The skin (usually the forearm or back) is cleaned with alcohol.
2. 2Application: The extract is applied as a small drop.
3. 3Puncture: A sterile device is used to prick the top layer of the skin.
4. 4Observation: The patient must remain in the office for at least 20 to 30 minutes to be monitored for a reaction.
5. 5Storage: Vials should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the vial upright and protected from light.

In the context of diagnostic testing, a missed dose simply means the test must be rescheduled. For immunotherapy, a missed dose can be critical. If a maintenance or escalation injection is missed, the next dose may need to be reduced to prevent an allergic reaction. Patients should contact their allergist immediately if a scheduled injection is missed.

An 'overdose' in the context of an allergenic extract refers to the administration of too much extract or a concentration that is too high for the patient's sensitivity level.

• Signs of Overdose: Large, painful local swelling (greater than 10 cm), hives (urticaria) all over the body, swelling of the throat, wheezing, or a drop in blood pressure.
• Emergency Measures: If a systemic reaction occurs, the immediate administration of epinephrine (Adrenalin) is required. The patient should be placed in a recumbent position and given oxygen or IV fluids as needed.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to use these extracts at home without medical guidance.

Because Melissa Officinalis Whole is designed to elicit an immune response, local reactions are expected and very common.

• Pruritus (Itching): Intense itching at the site of the skin test is the most frequent side effect. This usually begins within 5 minutes and lasts for 30 to 60 minutes.
• Erythema (Redness): A red 'flare' around the test site is a normal part of the diagnostic process.
• Wheal Formation: A raised, pale bump (similar to a mosquito bite) is the intended result of a positive test.
• Local Irritation: Some patients may experience a mild burning sensation when the extract (which contains glycerin) is first applied.

• Delayed Local Swelling: Some patients may develop a 'late-phase' reaction where the test site becomes swollen and hard 4 to 12 hours after the test. This is typically treated with cold compresses or topical corticosteroids.
• Persistent Itching: Itching that lasts for more than 24 hours at the site of the test.
• Mild Fatigue: Some patients report feeling tired or 'drained' after an allergy testing session, likely due to the body's inflammatory response.

• Lymphangitis: Very rarely, a red streak may develop extending from the test site, indicating inflammation of the lymph vessels.
• Vasovagal Reaction: Fainting or lightheadedness triggered by the needle prick or the sight of blood/needles, rather than the extract itself.
• Local Infection: As with any skin puncture, there is a remote risk of introducing bacteria into the skin, leading to cellulitis.

> Warning: Stop taking Melissa Officinalis Whole and call your doctor immediately if you experience any of these symptoms of Anaphylaxis.

• Respiratory Distress: Wheezing, shortness of breath, or a feeling of tightness in the chest.
• Angioedema: Swelling of the lips, tongue, or throat that makes swallowing or breathing difficult.
• Generalized Urticaria: Hives that spread to parts of the body far away from the test site.
• Hypotension: A sudden drop in blood pressure, which may feel like extreme dizziness or 'blacking out.'
• Tachycardia: A rapid or pounding heartbeat.

When used only for diagnostic purposes, there are no known long-term side effects of Melissa Officinalis Whole. If used as part of long-term immunotherapy, patients may rarely develop a permanent increase in sensitivity to the allergen or, conversely, may develop a desired long-term tolerance. There is no evidence that diagnostic use leads to the development of new allergies (sensitization).

Melissa Officinalis Whole extracts, like all allergenic extracts, carry a significant risk of severe systemic reactions.

FDA-Required Warning Summary:

• This product can cause anaphylaxis, which may be life-threatening.
• It should only be administered by healthcare professionals prepared to manage such reactions.
• Patients with unstable asthma are at a higher risk for fatal reactions.
• Patients taking beta-blockers may be resistant to the effects of epinephrine used during an emergency.

Report any unusual symptoms to your healthcare provider. Even a small local reaction can sometimes precede a more serious systemic reaction in highly sensitive individuals.

Melissa Officinalis Whole must be used with extreme caution. The primary safety concern is the risk of an IgE-mediated systemic allergic reaction. All testing and treatment must be conducted in a medical facility where an emergency kit, including epinephrine, is immediately available. Patients should be observed for at least 30 minutes following any administration of the extract.

No FDA black box warnings for Melissa Officinalis Whole specifically as a standalone drug, but it falls under the general class warning for Allergenic Extracts. The class warning emphasizes that these products are intended for use by physicians experienced in the diagnosis and treatment of allergies. Severe, life-threatening systemic reactions, including anaphylactic shock and death, can occur.

• Anaphylaxis Risk: This is the most significant risk. Patients who are 'highly sensitive' based on their medical history should be tested with much higher dilutions of the extract initially.
• Asthma Status: Patients experiencing an acute asthma exacerbation or those with poorly controlled asthma should not undergo skin testing or receive immunotherapy, as they are at a much higher risk for a severe respiratory reaction.
• Autoimmune Disorders: Patients with active autoimmune diseases may have unpredictable immune responses to allergenic extracts.
• Skin Conditions: Patients with extensive dermatitis, eczema, or dermographism (where the skin wheals easily from any touch) may yield 'false positive' results, making the test uninterpretable.

• Observation Period: A mandatory 20–30 minute wait in the clinic after administration.
• Baseline Vital Signs: Pulse and blood pressure should be checked if the patient feels unwell.
• Lung Function: In patients with a history of asthma, a peak flow or spirometry test may be performed before administration to ensure the patient is stable.

Generally, Melissa Officinalis Whole does not affect the ability to drive or operate machinery. However, if a patient experiences a vasovagal reaction (fainting) or a systemic allergic reaction, they should not drive until they are fully recovered and cleared by a physician.

There is no direct interaction between alcohol and Melissa Officinalis Whole extract. However, alcohol consumption can cause vasodilation and may theoretically increase the rate of absorption of the allergen or worsen the symptoms of an allergic reaction. It is best to avoid alcohol for several hours before and after allergy testing.

Discontinuing the use of Melissa Officinalis Whole for diagnostic purposes has no withdrawal effects. In immunotherapy, stopping treatment will result in a gradual loss of the built-up tolerance to the allergen, and symptoms upon natural exposure to lemon balm may return.

> Important: Discuss all your medical conditions with your healthcare provider before starting Melissa Officinalis Whole. Ensure your doctor knows if you have a history of heart disease or fainting.

There are no drugs that are strictly 'contraindicated' in the sense of causing a chemical reaction with the extract, but certain drugs make the use of the extract unsafe or ineffective:

• Beta-Blockers (e.g., Propranolol, Metoprolol): These drugs are contraindicated during allergy testing/treatment because they block the effects of epinephrine. If a patient has an anaphylactic reaction to Melissa Officinalis Whole, the rescue medication (epinephrine) may not work, leading to a potentially fatal outcome.

• ACE Inhibitors (e.g., Lisinopril): These may increase the risk of severe systemic reactions or worsen the severity of anaphylaxis.
• MAO Inhibitors (e.g., Phenelzine): Can potentiate the effects of sympathomimetic amines if they are needed for emergency treatment.

These drugs do not make the test unsafe, but they interfere with the results (causing false negatives):

• First-Generation Antihistamines (e.g., Diphenhydramine): Must be stopped at least 3–5 days before testing.
• Second-Generation Antihistamines (e.g., Loratadine, Cetirizine): Must be stopped at least 7 days before testing.
• H2 Blockers (e.g., Famotidine): May mildly suppress the skin response.
• Tricyclic Antidepressants (e.g., Amitriptyline): These have potent antihistamine properties and can suppress skin test reactions for up to 2 weeks.

• Cross-Reactive Foods: Patients allergic to Melissa Officinalis may also react to other Lamiaceae members like mint, basil, oregano, and sage. Consuming these foods shortly before a skin test might theoretically prime the immune system and lead to a larger-than-expected reaction.

• Lemon Balm Supplements: If a patient is taking oral Melissa Officinalis supplements, they should inform their doctor, as this may affect their baseline level of sensitivity during the test.
• St. John's Wort: May affect skin sensitivity to light and inflammation, though the direct interaction with allergenic extracts is not well-documented.

Melissa Officinalis Whole does not typically interfere with standard blood chemistry or hematology tests. Its only interaction is with Skin Prick Tests and Serum Specific IgE tests (RAST/ImmunoCAP), where the presence of the extract in the body's system (during immunotherapy) is intended to change these results over time.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any 'allergy pills' or 'cold and sinus' medications.

Melissa Officinalis Whole must NEVER be used in the following situations:

1. 1Previous Severe Systemic Reaction: If a patient has previously had a life-threatening anaphylactic reaction to Melissa Officinalis or any component of the extract (such as glycerin or phenol).
2. 2Unstable Asthma: Patients with a forced expiratory volume (FEV1) of less than 70% of predicted, or those with recent acute exacerbations, are at extreme risk of death if a systemic reaction occurs.
3. 3Active Skin Disease: Testing should not be performed on skin with active lesions, severe sunburn, or widespread dermatitis, as the results cannot be accurately read.

Conditions requiring careful risk-benefit analysis include:

• Pregnancy: While not a direct toxin, the risk of inducing anaphylaxis (which causes fetal hypoxia) means diagnostic testing is usually deferred until after delivery.
• Beta-Blocker Therapy: If the patient cannot safely discontinue beta-blockers, the risk of testing may outweigh the benefit.
• Severe Coronary Artery Disease: The stress of a potential systemic reaction or the administration of epinephrine could trigger a myocardial infarction (heart attack).

Patients with known allergies to other members of the Lamiaceae (Mint) family may show cross-sensitivity to Melissa Officinalis Whole. This includes:

• Mentha piperita (Peppermint)
• Salvia officinalis (Sage)
• Ocimum basilicum (Basil)
• Rosmarinus officinalis (Rosemary)
• Lavandula (Lavender)

> Important: Your healthcare provider will evaluate your complete medical history before prescribing or administering Melissa Officinalis Whole.

Pregnancy Category C: Animal reproduction studies have not been conducted with Melissa Officinalis Whole. It is not known whether the extract can cause fetal harm when administered to a pregnant woman. The primary concern is not the extract itself, but the potential for maternal anaphylaxis, which can lead to a sudden drop in blood pressure and oxygen delivery to the fetus, resulting in miscarriage or neurological damage. Consequently, most allergists recommend against starting new allergy testing or increasing immunotherapy doses during pregnancy.

It is not known whether the allergenic components of Melissa Officinalis Whole are excreted in human milk. Because systemic absorption from skin testing is so low, it is generally considered unlikely to affect a nursing infant. However, the decision to test should be made after a risk-benefit discussion with a healthcare provider.

Melissa Officinalis Whole is used in children as young as infants for diagnostic purposes.

• Safety: The safety profile is similar to that in adults.
• Dosing: No specific age-based dose reduction is required, but the number of tests performed at once is often reduced to prevent excessive discomfort.
• Conditions Not Approved: It is not approved for use in children with severe, uncontrolled asthma.

In patients over 65, the skin's reactivity to histamine and allergens typically decreases. This may lead to smaller wheal diameters, which could be misinterpreted as a negative result. Furthermore, elderly patients are more likely to have underlying cardiovascular disease, making them more vulnerable to the side effects of epinephrine if a systemic reaction occurs.

No adjustments are needed. The proteins in the extract are not cleared by the kidneys in a way that would lead to accumulation or toxicity in patients with GFR (Glomerular Filtration Rate) reductions.

No adjustments are needed. The liver does not play a significant role in the clearance of the small amounts of protein introduced during diagnostic testing.

> Important: Special populations require individualized medical assessment to ensure the benefits of diagnostic clarity outweigh the risks of the procedure.

Melissa Officinalis Whole acts as an antigen. Specifically, it provides the epitopes (binding sites) necessary to cross-link IgE antibodies on the surface of mast cells. This cross-linking activates the high-affinity IgE receptor (FcεRI), leading to an influx of calcium ions and the subsequent degranulation of the cell. This release of mediators (histamine, tryptase, heparin) causes the localized inflammatory response used for diagnosis.

• Onset of Action: The wheal and flare response typically begins within 5 to 10 minutes of administration.
• Peak Effect: The maximum size of the skin reaction is usually reached at 15 to 20 minutes.
• Duration: The primary wheal usually subsides within 1 to 2 hours, while the erythema (redness) may last up to 24 hours.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (Epicutaneous) |

| Protein Binding | N/A (Local tissue interaction) |

| Half-life | ~20-30 minutes (Local mediators) |

| Tmax | 15-20 minutes |

| Metabolism | Proteolytic degradation in tissue |

| Excretion | Lymphatic clearance |

• Composition: A complex mixture of proteins, glycoproteins, and secondary metabolites including rosmarinic acid (C18H16O8), citral, and geraniol.
• Solubility: The allergenic proteins are soluble in aqueous solutions and 50% glycerin.
• Molecular Weight: Ranges from small peptides (<10 kDa) to large glycoproteins (>100 kDa).

Melissa Officinalis Whole is classified as a Standardized Chemical Allergen [EPC] and a Non-Standardized Plant Allergenic Extract [EPC]. It is grouped with other botanical extracts like Mentha piperita and Salvia officinalis.